Harvard-MIT Health Sciences and Technology, Harvard Medical School, Massachusetts Institute of Technology, Boston, MA, USA.
Department of Neurosurgery, University at Buffalo, Buffalo, NY, USA.
Interv Neuroradiol. 2021 Apr;27(2):200-206. doi: 10.1177/1591019920956890. Epub 2020 Sep 15.
The Penumbra SMART coil is a novel device that becomes progressively softer from its distal to proximal end to maximize coil packing and prevent microcatheter prolapse or coil migration. Here, we report a large series of patients detailing the long-term experience of a single institution using the SMART coil among patients with intracranial aneurysms (IAs).
Prospective data of 105 consecutive patients with 106 IAs treated using SMART coils was collected between March 2015 and July 2018. Clinical and angiographic data were analyzed.
Forty-nine patients (46.7%) presented with subarachnoid hemorrhage and 16 (14.2%) had recurrent aneurysms. Two patients had minor intraprocedural ruptures and remained neurologically stable. One patient had a thromboembolic complication with progressive neurologic decline. There was only one case microcatheter prolapse related to placement of a stent before coiling. An initial post-treatment modified Raymond-Roy Occlusion Classification (mRROC) I or II closure was achieved in 56 (52.8%) aneurysms. The average time to last follow-up was 8.4 months at which 70 (81.4%) aneurysms had mRROC I or II occlusion and a major recurrence was seen in 5 (5.8%) patients. Thirteen (12.3%) aneurysms required re-treatment of which one aneurysm was clipped.
The Penumbra SMART coil is safe and effective for the endovascular treatment of appropriately selected IAs. Additional studies at multiple centers comparing safety and efficacy profile over long-term periods to other mainstream coils are necessary.
Penumbra SMART 线圈是一种新型装置,其远端至近端逐渐变软,以最大限度地增加线圈的包装密度,并防止微导管脱出或线圈迁移。在此,我们报告了一个大型系列患者的长期经验,详细介绍了一家机构在颅内动脉瘤(IA)患者中使用 SMART 线圈的情况。
2015 年 3 月至 2018 年 7 月,连续收集了 105 例 106 个 IA 患者使用 SMART 线圈治疗的前瞻性数据。分析了临床和血管造影数据。
49 例(46.7%)患者出现蛛网膜下腔出血,16 例(14.2%)患者有复发性动脉瘤。2 例患者术中发生轻微破裂,神经状态稳定。1 例患者发生血栓栓塞并发症,神经功能逐渐下降。只有 1 例微导管脱出与支架置入后线圈放置有关。56 例(52.8%)动脉瘤在初始治疗后达到改良 Raymond-Roy 闭塞分类(mRROC)Ⅰ或Ⅱ级闭塞。最后一次随访的平均时间为 8.4 个月,70 例(81.4%)动脉瘤达到 mRROC Ⅰ或Ⅱ级闭塞,5 例(5.8%)患者出现主要复发。13 例(12.3%)动脉瘤需要再次治疗,其中 1 例动脉瘤被夹闭。
Penumbra SMART 线圈对于适当选择的 IA 的血管内治疗是安全有效的。需要在多个中心进行比较安全性和长期疗效的研究,以与其他主流线圈进行比较。